Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis

This study has been completed.
Sponsor:
Collaborator:
Bill and Melinda Gates Foundation
Information provided by:
Immtech Pharmaceuticals, Inc
ClinicalTrials.gov Identifier:
NCT00802594
First received: December 3, 2008
Last updated: December 4, 2008
Last verified: December 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2004
  Primary Completion Date: August 2002 (Final data collection date for primary outcome measure)